Literature DB >> 31949692

The expressions of YAP1, β-catenin and survivin in colon cancer tissues and their clinical significance.

Qianwen Shao1, Jing Xu2, Rong Deng3, Wei Wei3, Bing Zhou3, Chao Yue3, Miaoling Zhu4, Haitao Zhu5.   

Abstract

We aimed to evaluate the effects of YAP1, β-catenin, and survivin on the onset and progression of colon cancer, and to explore their correlations. The expressions of YAP1, β-catenin, and survivin in 106 colon cancer tissues and 55 normal colon mucosa tissues were measured by immunohistochemical assay. The correlations between their expressions and clinical and pathological characteristics were analyzed. The expression rates of YAP1, β-catenin, and survivin in colon cancer tissues were significantly higher than those in normal colon mucosa tissues (P<0.001). The expressions of YAP1, β-catenin, and survivin in colon cancer were correlated with neither gender nor age (P>0.05), but with the degree of differentiation, depth of invasion, lymph node metastasis and Duke's stage (P<0.05). Pearson's correlation analysis showed that the expressions of YAP1, β-catenin, and survivin in colon cancer tissues were all positively correlated (P<0.05). The overexpression of YAP1, β-catenin, and survivin played an important role in the onset and progression of colon cancer, providing reference value for prognosis prediction. IJCEP
Copyright © 2018.

Entities:  

Keywords:  YAP1; colon cancer; survivin; β-catenin

Year:  2018        PMID: 31949692      PMCID: PMC6963090     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  18 in total

1.  Effect of survivin on cell proliferation and apoptosis in gastric cancer.

Authors:  Yoichi Wakana; Kazuhiko Kasuya; Soh Katayanagi; Akihiko Tsuchida; Tatsuya Aoki; Yasuhisa Koyanagi; Hideaki Ishii; Yoshiro Ebihara
Journal:  Oncol Rep       Date:  2002 Nov-Dec       Impact factor: 3.906

2.  Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.

Authors:  K Tanaka; S Iwamoto; G Gon; T Nohara; M Iwamoto; N Tanigawa
Journal:  Clin Cancer Res       Date:  2000-01       Impact factor: 12.531

3.  Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.

Authors:  Zheying Zhang; Chang Zhou; Yaya Chang; Zuoyang Zhang; Yuhan Hu; Fan Zhang; Yanxia Lu; Lin Zheng; Wenjuan Zhang; Xiaomin Li; Xuenong Li
Journal:  Cancer Lett       Date:  2016-03-21       Impact factor: 8.679

Review 4.  Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.

Authors:  Bryan D White; Andy J Chien; David W Dawson
Journal:  Gastroenterology       Date:  2011-12-08       Impact factor: 22.682

Review 5.  YAP oncogene overexpression supercharges colon cancer proliferation.

Authors:  Joseph Avruch; Dawang Zhou; Nabeel Bardeesy
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

Review 6.  Beta-catenin and the morphogenesis of colorectal cancer.

Authors:  Thomas Brabletz; Andreas Jung; Thomas Kirchner
Journal:  Virchows Arch       Date:  2002-04-27       Impact factor: 4.064

7.  Clinical significance of yes-associated protein overexpression in cervical carcinoma: the differential effects based on histotypes.

Authors:  Tianbo Liu; Yunduo Liu; Hongyu Gao; Fanling Meng; Shanshan Yang; Ge Lou
Journal:  Int J Gynecol Cancer       Date:  2013-05       Impact factor: 3.437

Review 8.  Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.

Authors:  Leos Kren; Jan Brazdil; Marketa Hermanova; Viktor N Goncharuk; Bhaskar V S Kallakury; Prabhjot Kaur; Jeffrey S Ross
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-03

9.  Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.

Authors:  Anil Belur Nagaraj; Peronne Joseph; Olga Kovalenko; Sareena Singh; Amy Armstrong; Raymond Redline; Kimberly Resnick; Kristine Zanotti; Steven Waggoner; Analisa DiFeo
Journal:  Oncotarget       Date:  2015-09-15

10.  MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.

Authors:  Ling Xiao; Hui Zhou; Xiang-Ping Li; Juan Chen; Chao Fang; Chen-Xue Mao; Jia-Jia Cui; Wei Zhang; Hong-Hao Zhou; Ji-Ye Yin; Zhao-Qian Liu
Journal:  Oncotarget       Date:  2016-06-28
View more
  2 in total

1.  Targeting Yes1 Associated Transcriptional Regulator Inhibits Hepatocellular Carcinoma Progression and Improves Sensitivity to Sorafenib: An in vitro and in vivo Study.

Authors:  Liwen Guo; Jiaping Zheng; Jun Luo; Zhewei Zhang; Guoliang Shao
Journal:  Onco Targets Ther       Date:  2020-10-29       Impact factor: 4.147

2.  Investigation of Colonic Regeneration via Precise Damage Application Using Femtosecond Laser-Based Nanosurgery.

Authors:  Sören Donath; Leon Angerstein; Lara Gentemann; Dominik Müller; Anna E Seidler; Christian Jesinghaus; André Bleich; Alexander Heisterkamp; Manuela Buettner; Stefan Kalies
Journal:  Cells       Date:  2022-03-28       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.